FDA Public Comment – Hims & Hers Health, Inc. on Compounding of Human Drug Products (Dkt. No. FDA‑2015‑N‑0030; Filed 11/15/2024)

FDA Public Comment – Hims & Hers Health, Inc. on Compounding of Human Drug Products (Dkt. No. FDA‑2015‑N‑0030; Filed 11/15/2024)

Regular price $69.00 USD
Regular price Sale price $69.00 USD
Sale Sold out
Original Request Contents: Public Comment from Hims & Hers Health, Inc. on compounding of human drug products under the FDCA, Dkt. No. FDA‑2015‑N‑0030 (filed November 15, 2024), as per attached Status Report
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details